[{"Assets_0_FY_USD":187239270.0,"CommonStockSharesOutstanding_0_FY_shares":90357644.0,"EarningsPerShareBasic_1_FY_USD":-0.24,"EarningsPerShareBasic_4_FY_USD":-1.08,"EarningsPerShareDiluted_1_FY_USD":-0.24,"EarningsPerShareDiluted_4_FY_USD":-1.09,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-63208921.0,"NetIncomeLoss_1_FY_USD":-21506179.0,"NetIncomeLoss_4_FY_USD":-88205772.0,"StockholdersEquity_0_FY_USD":142392540.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":81918022.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":81777493.0,"Ticker":"INO","CIK":"1055726","name":"INOVIO PHARMACEUTICALS, INC.","OfficialName":"Inovio Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"674206680.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20180314"}]